Holen Sie sich die Stockscreener-App
8.95
0.33%
-0.03
Schlusskurs vom Vortag:
$8.98
Offen:
$9.04
24-Stunden-Volumen:
29,554
Relative Volume:
0.36
Marktkapitalisierung:
$518.56M
Einnahmen:
$174.79M
Nettoeinkommen (Verlust:
$20.44M
KGV:
25.20
EPS:
0.3552
Netto-Cashflow:
$18.93M
1W Leistung:
+0.22%
1M Leistung:
+7.06%
6M Leistung:
+25.35%
1J Leistung:
+26.41%
1-Tages-Spanne:
$8.94
$9.11
1-Wochen-Bereich:
$8.591
$9.24
52-Wochen-Spanne:
$5.54
$9.35
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
8.99 | 517.98M | 174.79M | 20.44M | 18.93M | 0.3552 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.30 | 57.09B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
121.58 | 51.65B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.24 | 45.70B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.66 | 36.69B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
538.76 | 23.19B | 3.13B | 1.27B | 1.12B | 26.39 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Eingeleitet | The Benchmark Company | Buy |
| 2024-07-03 | Eingeleitet | Stifel | Buy |
| 2018-02-02 | Eingeleitet | Chardan Capital Markets | Buy |
Kamada Ltd Aktie (KMDA) Neueste Nachrichten
Day Trade: Can Kamada Ltd generate free cash flowJuly 2025 WrapUp & Weekly Stock Breakout Alerts - baoquankhu1.vn
Trading Recap: Is Kamada Ltd stock a buy or sell2025 Analyst Calls & Weekly Top Performers Watchlists - baoquankhu1.vn
Setup Watch: Is Kamada Ltd stock overvalued or fairly pricedWeekly Earnings Recap & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Dow Update: Is Kamada Ltd a potential multi bagger2025 Price Targets & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Big Picture: Can Kamada Ltd disrupt its industry2025 Volatility Report & Stepwise Trade Execution Plans - baoquankhu1.vn
Ahead of Kamada (KMDA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Kamada Sets March 11, 2026 Date to Report Fiscal 2025 Results - TipRanks
Kamada schedules release of fiscal year and Q4 2025 results for March 11 - Investing.com
Kamada (NASDAQ: KMDA) schedules March 11 call on 2025 results - Stock Titan
Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026 - GlobeNewswire
Setup Watch: Can Kamada Ltd disrupt its industryJuly 2025 Macro Moves & Daily Stock Momentum Reports - baoquankhu1.vn
Kamada Ltd. (KMDA) Stock Analysis: Unveiling a 45.9% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat
Kamada Ltd expected to post earnings of 8 cents a shareEarnings Preview - TradingView
Kamada (KMDA) Projected to Post Earnings on Wednesday - MarketBeat
Kamada (NASDAQ:KMDA) Reaches New 12-Month HighStill a Buy? - MarketBeat
Market Leaders: Can Kamada Ltd generate free cash flowTrade Ideas & Short-Term High Return Strategies - baoquankhu1.vn
Can Kamada Ltd. generate free cash flowWeekly Market Summary & Detailed Earnings Play Strategies - mfd.ru
Can Kamada Ltd. outperform in the next rallyTreasury Yields & Advanced Swing Trade Entry Plans - mfd.ru
Kamada Ltd. (KMDA) Stock Analysis: Exploring A 50% Upside Potential - DirectorsTalk Interviews
Kamada (NASDAQ:KMDA) Sets New 52-Week HighStill a Buy? - MarketBeat
Are Investors Undervaluing Kamada (KMDA) Right Now? - Yahoo Finance
Will Kamada Ltd. stock reach all time highs in 2025Short Setup & Entry Point Confirmation Signals - mfd.ru
Can Kamada Ltd. disrupt its industryJuly 2025 Chart Watch & Free Verified High Yield Trade Plans - mfd.ru
Is Kamada Ltd. stock a buy or sellJuly 2025 Spike Watch & High Accuracy Swing Entry Alerts - mfd.ru
Kamada Ltd. (KMDA) Stock Analysis: Unveiling a 51.69% Potential Upside in Healthcare Investments - DirectorsTalk Interviews
Will Kamada Ltd. stock gain from government policiesWall Street Watch & Risk Managed Investment Entry Signals - mfd.ru
Is Kamada Ltd. exposed to political riskTrade Exit Summary & Growth Oriented Trading Recommendations - mfd.ru
Does Kamada Ltd. stock trade at a discount to peersEarnings Overview Summary & Pattern Based Trade Signal System - mfd.ru
Sentiment Review: Is Kamada Ltd exposed to political riskCEO Change & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Is Kamada Ltd exposed to political riskWeekly Trading Summary & AI Powered Market Entry Strategies - baoquankhu1.vn
Aug Intraday: Can Kamada Ltd navigate macro headwindsPortfolio Return Report & Daily Profit Maximizing Tips - baoquankhu1.vn
Kamada (TLV:KMDA) shareholder returns have been favorable, earning 74% in 3 years - simplywall.st
Can Kamada Ltd. continue delivering strong returnsJuly 2025 Gainers & Verified Chart Pattern Signals - mfd.ru
Pharma News: Will Kamada Ltd outperform the market in YEAR2025 Short Interest & Weekly Top Stock Performers List - baoquankhu1.vn
Kamada (KMDA) Soars 8.1%: Is Further Upside Left in the Stock? - Yahoo Finance
Volume Summary: Is Kamada Ltd a potential multi baggerTrade Entry Summary & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Kamada Ltd. (KMDA) Stock Analysis: Exploring a 62.91% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Kamada Ltd: Biopharma under Pressure as KMDA Stock Tests Investor Patience - AD HOC NEWS
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market - openPR.com
Is Kamada Ltd. stock a safe investment in uncertain marketsSector ETF Performance & Fast Growing Trading Plans - Bollywood Helpline
Kamada Ltd. (KMDA) Stock Analysis: Exploring A 58.15% Upside In The Healthcare Space - DirectorsTalk Interviews
Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio | Corporate - EQS News
Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio - NewMediaWire
Kamada Projects Strong 2026 Growth Fueled by Plasma Portfolio and Distribution Expansion - citybuzz -
Kamada shares climb after upbeat 2026 outlook points to double-digit growth - MSN
HC Wainwright Issues Optimistic Forecast for Kamada Earnings - Defense World
Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN
Q1 Earnings Forecast for Kamada Issued By HC Wainwright - Defense World
Kamada Ltd. (KMDA) Stock Analysis: Unpacking a 63.52% Potential Upside in Healthcare Innovation - DirectorsTalk Interviews
Q1 Earnings Estimate for Kamada Issued By HC Wainwright - MarketBeat
Finanzdaten der Kamada Ltd-Aktie (KMDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.88%
1.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):